Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates
- 1 May 1990
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 116 (5), 791-797
- https://doi.org/10.1016/s0022-3476(05)82674-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Pharmacokinetics and adverse effects of amphotericin B in infants and childrenThe Journal of Pediatrics, 1988
- Pharmacokinetics of Amphotericin B in Infants and ChildrenThe Journal of Infectious Diseases, 1987
- Distribution and Activity of Amphotericin B in HumansThe Journal of Infectious Diseases, 1985
- Computation of Model-Independent Pharmacokinetic Parameters During Multiple DosingJournal of Pharmaceutical Sciences, 1983
- Candida endophthalmitis in the premature infantThe Journal of Pediatrics, 1981
- Assay of flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatographyAntimicrobial Agents and Chemotherapy, 1979
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979
- Quantitation of Amphotericin B with Use of High-Pressure Liquid ChromatographyThe Journal of Infectious Diseases, 1977
- Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin BThe Journal of Infectious Diseases, 1975
- A Pharmacologic Guide to the Clinical Use of Amphotericin BThe Journal of Infectious Diseases, 1969